August 2022 Issue Table Of Contents

From The Editor

• Representation Matters. Location Does Too.

Feature Articles

• Alnylam’s Challenge: Scaling Up And Moving Beyond The Liver
• KemPharm: Converting FDA Complete Response Letters Into New Opportunities

CEO Corner

• Peeling Back The Layers Of The Digital Health Onion
• How Diversity And Motherhood Fortified Me As A Women’s Health CEO

Companies To Watch

• Priothera

Industry Research

• Predicted Changes In Outsourcing Rates For Highly Potent API

Podcast Summary

• Venture Philanthropy Launches Biotech From Within

Inside The Industry

• Living Diversity, Inside Mink Therapeutics
• 5 Golden Opportunities For Life Sciences Talent Acquisition
• Gene Therapy Competitive Dynamics: Winner Takes All?
• The “Renaissance” Approach To Cell & Gene Therapy Manufacturing
• Strong Company Culture: The Answer To The Great Resignation
• Outsourcers Who Most Heavily Rely On CDMOs Often Lack CDMO Selection Resources

Industry Leader

• Supply Chain Problems: Overcoming The Challenges
• The Insurance Implications Of Global Clinical Trials
• How Do I Participate In The Legislative Process?
• Addressing Health Inequities With RWE: Not Just Lip Service

Leadership Lessons

• Are Rigorous Scientific Debates A Thing Of The Past?

Ask The Board

• Aside From Publications, What Can Academic Scientists Do To Promote Their Research And Discoveries To Potential Licensees Or Drug Developers?
• What Skills Distinguish The More Successful People Working In Healthcare From People Working In Other Sectors?